Benlysta 200 MG/ML autoinjectml
Ended Awarded
- Contract number
- SPE2DB26FABV8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,331
Award facts
- Contract value 100% obligated
- $12,330.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Benlysta 200 mg/mL auto-injector with a ceiling value of $12,330.68. This is a firm fixed price delivery order with an ultimate completion date of December 3, 2025, and represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. The Benlysta auto-injector procurement supports the Defense Health Agency and other government healthcare customers through DLA's pharmaceutical supply chain. As a major vendor capable of meeting federal requirements through open competition, AmerisourceBergen maintains an extensive portfolio of medical product deliveries with the Defense Logistics Agency, positioning it as a key supplier for the Department of Defense's pharmaceutical and medical supply needs.
Quick answers
Who was awarded contract SPE2DB26FABV8?
SPE2DB26FABV8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FABV8 worth?
The government has obligated $12,331 on SPE2DB26FABV8.
Is contract SPE2DB26FABV8 an order under another contract?
Yes. SPE2DB26FABV8 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB26FABV8 competed?
The extent of competition for SPE2DB26FABV8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award